Composite Health Assessment Risk Model (CHARM) for Older Adults
Last updated on July 2021Recruitment
- Recruitment Status
- Recruiting
- Estimated Enrollment
- Same as current
Summary
- Conditions
- Hematologic Malignancy
- Type
- Observational
- Design
- Observational Model: CohortTime Perspective: Prospective
Participation Requirements
- Age
- Between 60 years and 125 years
- Gender
- Both males and females
Description
At baseline, standardized Geriatric Assessment (GA) tools incorporating subject reported data and bedside testing will be collected. HCT-Comorbidity Index (CI) scores will be assigned and C-reactive protein (CRP) and albumin will be measured locally. Serial measures at 3, 6, and 12 months for frailt...
At baseline, standardized Geriatric Assessment (GA) tools incorporating subject reported data and bedside testing will be collected. HCT-Comorbidity Index (CI) scores will be assigned and C-reactive protein (CRP) and albumin will be measured locally. Serial measures at 3, 6, and 12 months for frailty, skilled facility admission, and quality of life (QOL) using PROMIS measures for physical function, depression and anxiety will be determined. Graft Versus Host Disease (GVHD) through one year, serious toxicities through day 100, cognitive status at day 100 and causes of death will be captured.
Tracking Information
- NCT #
- NCT03992352
- Collaborators
- National Institutes of Health (NIH)
- National Heart, Lung, and Blood Institute (NHLBI)
- National Cancer Institute (NCI)
- Blood and Marrow Transplant Clinical Trials Network
- National Marrow Donor Program
- Investigators
- Principal Investigator: Andrew Artz, MD, MS City of Hope Medical Center Principal Investigator: Mohamed Sorror, MD, MSc Fred Hutchinson Cancer Research Center Study Chair: Wael Saber, MD, MS Medical College of Wisconsin/CIBMTR